ORIGINAL RESEARCH
Published on 26 Sep 2022
Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamide
doi 10.3389/fonc.2022.900082
- 1,854 views
- 5 citations
